Day: May 31, 2021
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific [...]